By Steven Reinberg HealthDay Reporter
MONDAY, June 20, 2022 (HealthDay News)
Americans may have a collective drinking problem, made worse by the obesity epidemic, new research suggests. The new study found that deaths from alcoholic cirrhosis have more than tripled in 20 years.
In 1999, alcoholic cirrhosis — an advanced form of alcohol-related liver disease — killed just over 6,000 Americans (a rate of 3 per 100,000). By 2019, deaths from the condition had soared to nearly 24,000 (a rate of 11 per 100,000).
“The hypothesis is that people are drinking more and starting earlier in life,” said lead researcher Dr. Charles Hennekens, the First Sir Richard Doll Professor & Senior Academic Adviser to the Dean at the Charles E. Schmidt College of Medicine at Florida Atlantic University in Boca Raton.
But there may be other factors at work, Hennekens added, including a dramatic increase in obesity, along with more sedentary lifestyles.
“That leads to fatty liver,” Hennekens said. “The same kind of thing that alcohol does. My hypothesis is that the reason we’re seeing more of liver disease earlier is not just that people are drinking more, but that they’re eating more and exercising less, so the damage to the liver is accelerating.”
Hennekens said that as far as drinking goes, people should limit the amount of alcohol they drink to no more than two drinks a day for men and no more than one for women.
“While the data indicate that those who have one to two drinks daily have lower risks of cardiovascular disease than nondrinkers, it is also true that the difference between drinking smaller and larger amounts of alcohol means the difference between preventing and causing premature death,” Hennekens said.
The investigators found that during those two decades there were statistically significant increases in deaths from alcoholic cirrhosis in every age group from 25 and up. The largest increase was sevenfold among those aged 24 to 35 and the steepest increase was seen among those aged 65 to 74.
The report was published online recently the American Journal of Medicine.
“The rising prevalence of high-risk drinking and alcohol use disorder has fueled these trends in the development of chronic liver disease and its complications,” she said. “Although effective treatments are available for alcohol use disorder, they are currently underutilized.”
Barriers to care include other medical conditions, the stigma around addiction and limited access to care, Wu said.
“Existing care delivery models have been further restricted due to challenges related to the pandemic,” she said. “Thus, there is an urgent need to improve methods of identifying individuals with high risk for developing disease, and also to utilize novel digital platforms and technology to personalize treatment and prevention.”
For more on liver disease, head to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.
SOURCES: Charles Hennekens, MD, DrPH, First Sir Richard Doll Professor & Senior Academic Adviser to the Dean, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton; Tiffany Wu, MD, gastroenterologist, Mayo Clinic, Rochester, Minn.; American Journal of Medicine, May 27, 2022, online
Copyright © 2021 HealthDay. All rights reserved.